NCT01366820 - Study of NNZ-2566 in Patients With Traumatic Brain Injury Under EFIC | Biotech Hunter

Enrollment

261

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Brain Injuries

Interventions

DRUG

NNZ-2566

"Solution for intravenous infusion.~Intravenous bolus infusion over 10 minutes followed by a continuous intravenous maintenance infusion for a total of 72 consecutive hours."

DRUG

Placebo

Sodium Chloride 0.9% Injection

Trial Locations (6)

15213

University of Pittsburgh Medical Center, Pittsburgh

48201

Detroit Receiving Hospital and University Health Center, Detroit

48235

Sinai Grace Hospital, Detroit

92324

Arrowhead Regional Medical Center, Colton

95817

University of California, Davis Medical Center, Sacramento

96813

The Queen's Medical Center, Honolulu